| Impacts of Treatment Lines and Initiation Timing of Erlotinib for Advanced Non-small Cell Lung Cancer |
PDF
|
|
TAKUYA AOKI, SATOSHI IGAWA, NAOKI FURUYA, MASATO KATAGIRI, JUNICHIROU HISATA, SAKURAKO TAJIRI, NAOKI HAYAMA, MASAMICHI MINESHITA, TETSUYA URANO, TERUOMI MIYAZAWA, NORIYUKI MASUDA, TADASHI ABE |
601-608 |
| Intermediate Oncological Outcomes of Percutaneous Radiofrequency Ablation for Small Renal Tumors: Initial Experience |
PDF
|
|
YUJIRO NITTA, TOMOAKI TANAKA, KAZUYA MORIMOTO, TETSUYA MAKINO, NORIAKI NISHIKAWA, KOUICHIRO TASHIRO, TOSHIHIDE NAGANUMA, TARO IGUCHI, TOSHIYUKI MATSUOKA, TATSUYA NAKATANI |
615-618 |
| A Randomized Comparison of Modified Intermediate-dose Ara-C versus High-dose Ara-C in Post-remission Therapy for Acute Myeloid Leukemia |
PDF
|
|
TOSHIHIRO FUKUSHIMA, YOSHIMASA URASAKI, MASAKI YAMAGUCHI, MIKIO UEDA, KOJI MORINAGA, TOSHIHIRO HABA, TOSHIRO SUGIYAMA, SHINJI NAKAO, HIDEKI ORIGASA, HISANORI UMEHARA, TAKANORI UEDA |
643-647 |
